Corpus Intelligence IC Memo — UT HEALTH EAST TEXAS CARTHAGE HOSPIT 2026-04-26 12:29 UTC
IC Memo — UT HEALTH EAST TEXAS CARTHAGE HOSPIT
Investment Committee Memorandum | TX | 42 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UT HEALTH EAST TEXAS CARTHAGE HOSPIT

CCN 450210 | PANOLA, TX | 42 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

UT HEALTH EAST TEXAS CARTHAGE HOSPIT is a 42-bed community hospital in PANOLA, TX with $20.7M in net patient revenue and a -3.2% operating margin. The hospital serves a payer mix of 37.2% Medicare, 0.0% Medicaid, and 62.8% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.2% to 4.2% (+736bps).

Net Revenue HCRIS$20.7M
Current EBITDA COMPUTED$-660K
Operating Margin COMPUTED-3.2%
Occupancy HCRIS7.9%
Revenue / Bed COMPUTED$493K
Net-to-Gross HCRIS15.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
283
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -3.2% places it below the state median. Among 283 size-comparable peers (21-84 beds), the median margin is -2.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 283 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UT HEALTH EAST TEXAS CARTHAGE (Target)TX42$20.7M-3.2%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$435K+210bp18mo
Cost to Collect4.5%2.5%$415K+200bp12mo
Denial Rate Reduction12.0%6.5%$410K+198bp12mo
A/R Days Reduction5200.0%3800.0%$252K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$435K
Cost to Collect
$415K
Denial Rate Reduction
$410K
A/R Days Reduction
$252K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-660K
+ RCM Uplift+$1.5M
Pro Forma EBITDA$866K
Current Margin-3.2%
Pro Forma Margin4.2%
WC Released (1x)$795K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.0M$10.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.0M$11.7M0.00x-100.0%
Bull Case9.0x11.0x$-913K$16.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-913K$17.6M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$3.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$3.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 7.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 283 hospitals with 21-84 beds
  • Same-state prioritization (n=284)
  • Comp margins: P25=-22.7% / P50=-2.4% / P75=10.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.